ABH Healthcare IPO Analysis: Should You Apply? GMP, Review & Details

ABH Healthcare is a SME IPO in the Pharmaceuticals sector. The issue price band is ₹96.0–₹102.0 per share. Issue size is ₹34.98 crore.

ABH Healthcare IPO — Key Details

Company Overview

ABH Healthcare Ltd provides healthcare services under the name 'Anil Baghi Hospital', featuring 150 beds and offering 25 medical specialties such as cardiac sciences, neurology, and various surgical procedures. The hospital collaborates with 30 health insurance providers and participates in government healthcare schemes. As of March 31, 2025, the hospital employs 29 doctors and 137 nurses, showcasing a robust healthcare service infrastructure.

Financial Performance

Total income was ₹41.39 Cr in the year ending 31 Mar 2024, rising to ₹49.32 Cr by 31 Mar 2025, and further increasing to ₹52.59 Cr by 31 Mar 2026. This indicates a consistent upward trend in revenue over the periods analyzed. Profit after tax was ₹1.66 Cr in the year ending 31 Mar 2024, increasing to ₹5.35 Cr by 31 Mar 2025, and further rising to ₹5.64 Cr by 31 Mar 2026. This shows a positive growth in profit over the analyzed periods.

Objects of the Issue

The company plans to use the proceeds from the IPO for several purposes: ₹17.00 Cr for repayment or prepayment of certain borrowings, ₹5.00 Cr for funding working capital requirements, ₹8.62 Cr for funding inorganic growth through acquisitions and general corporate purposes, and ₹4.36 Cr for issue expenses.

Strengths & Weaknesses

Strengths

ABH Healthcare has a doctor-led management team with proven execution capabilities, offers high-quality clinical care, operates across diverse clinical specialties, and has a robust infrastructure supported by modern technology.

Understanding Grey Market Premium (GMP)

The grey market refers to the unofficial trading of shares before they are listed on the stock exchange. The Grey Market Premium (GMP) indicates the expected listing price of an IPO based on demand and supply dynamics. A higher GMP suggests strong demand, while a lower or negative GMP indicates weaker demand.

Subscription Status

As of 27th Aug 2026, the IPO was subscribed 1.44 times overall. The institutional category (QIB) saw a strong response with a subscription of 8.37 times, while the retail category (RII) was subscribed 1.69 times. However, the non-institutional categories (NII) and (bNII) saw lower interest, with subscriptions of 0.29 times and 0.15 times, respectively.

Peer Comparison

• Asarfi Hospital Limited: NAV 49.62, RoNW 18.65%, P/E 27.63
• Maitreya Medicare Limited: NAV 42.67, RoNW -8.1%, P/E -34.11
• Sangani Hospitals Limited: NAV 23.3, RoNW 16.2%, P/E 24.52
• ABH Healthcare Limited: NAV 21.58, RoNW 34.26%, P/E 14.47

IPO Timeline

The IPO opens for subscription from 24th August 2026 to 26th August 2026, with the allotment date scheduled for 28th August 2026 and the listing date on 1st September 2026.

Should You Apply for ABH Healthcare IPO?

Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their overall portfolio strategy and risk tolerance. It is important to consider the company's fundamentals and market conditions before making an investment decision.

Investors who are risk-averse or prefer stable, well-established companies may want to avoid IPOs like this, which can be subject to market fluctuations and uncertainties inherent in new listings.

This is general risk-profile education, not a personal recommendation to apply or avoid this specific IPO — TopFund is not a SEBI-registered investment adviser.

Listing Day Risks

Listing gains refer to the potential profit an investor can make when shares are listed on the stock exchange and traded for the first time. However, there are risks associated with relying on listing gains, as market conditions can fluctuate, and the actual listing price may differ from expectations.

Trending Searches

Disclaimer: This is educational content, not investment advice. GMP is an unofficial grey-market indicator, unregulated and never guaranteed. TopFund is not a SEBI-registered investment adviser — please do your own research or consult a qualified adviser before applying to any IPO.